Understanding how the PLP1 gene is controlled in humans and mice
Elucidation of Mechanisms Controlling Human and Mouse Myelin PLP1 Gene Expression
This study is looking at how certain parts of the PLP1 gene, which is important for making myelin in the nervous system, work and how changes in these parts can cause conditions like Pelizaeus-Merzbacher disease and spastic paraplegia type 2, with the hope of finding new ways to help people with these diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10599083 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that regulate the expression of the PLP1 gene, which is crucial for myelin formation in the nervous system. By using transgenic mice that express a reporter gene linked to the PLP1 gene, researchers aim to identify specific regulatory regions that control gene expression. The study focuses on understanding how mutations in these regulatory regions can lead to diseases like Pelizaeus-Merzbacher disease and spastic paraplegia type 2. This research could provide insights into genetic factors that contribute to these conditions, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Pelizaeus-Merzbacher disease or spastic paraplegia type 2, particularly those with unexplained cases.
Not a fit: Patients with PLP1 mutations that have already been characterized or those without any leukodystrophy-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with leukodystrophies caused by PLP1 mutations.
How similar studies have performed: Previous research has shown success in understanding gene regulation mechanisms in other genetic disorders, suggesting that this approach may yield valuable insights.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Wight, Patricia a. — Univ of Arkansas for Med Scis
- Study coordinator: Wight, Patricia a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.